You are not logged in. | Log in

SIDRA

GXB

Clear Search
Updating...
Gene Symbol: --
Log2 Signal: --
Sample ID: --
Full Name--
Summary--
Links
Pubmed Articles --
User Notes --
Description

Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells - GSE87399

Purpose
Hypothesis
Allergen-specific immunotherapy has major effects on the frequency of peripheral Tfh and Tfr cells, which may be regulated by IL-2
Experimental Design
RNA-sequencing of sorted memory CXCR5 high and CXCR5low T cells from cryopreserved PBMC of 5 subjects with allergy and 5 patients undergoing allergen-specific immunotherapy
Experimental Variables

Allergy and allergen-specific immunotherapy.

Controls

5 subjects with allergy.

Methods

The single-end reads that passed Illumina filters were filtered for reads aligning to tRNA, rRNA, adapter sequences, and spike-in controls.RNA-Seq data was mapped against hg19 reference genome using tophat (v1.4.1., --library-type fr-secondstrand -C) and the RefSeq gene annotation downloaded from the UCSC genome bioinformatics site.The alignment results (sam files) were converted into bam files and sorted by using samtools.DUST scores were calculated with PRINSEQ Lite (v 0.20.3) and low-complexity reads (DUST > 4) were removed from the BAM files.Sequencing read coverage per gene was counted using HTSeq-count (-m union -s yes -t exon -i gene_id).Genome_build: hg19Supplementary_files_format_and_content: [.txt] file reports raw counts of sequencing reads per gene generated by HTSeq-count

Additional Information

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE87399

Platform Ensembl Human v37
No information available.
Default files:

Signal Data File

Download Annotations for Group Set:
Download Annotations for Group:
Download Ranklist:
Your email has been sent!
Advanced
Yes No
Yes No
X-axis Y-axis Both None
Yes No
Rank Lists
Group Set
Sort By
      Bar Plot Box Plot
    Overlays
      Updating...
      Your bug report has been sent!
      Sample Set Level   Dataset Level   Gene Level
      Your note has been added
      Loading...